Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety

Author： Salim Imtiaz Al Suwaidi Jassim Ghadban Wissam Salam Amar M

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.12, Iss.1, 2013-01, pp. : 53-63

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anticoagulation prescription in atrial fibrillation

By Bertomeu-Gonzáález Vicente Cordero Alberto Mazóón Pilar Moreno-Arribas Joséé Fáácila Lorenzo Nuññez Julio Rodrííguez-Maññero Moiséés Cosíín-Sales Juan Gonzáález-Juanatey Jose Ramóón Quiles Juan Bertomeu-Martíínez Vicente

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 10, 2011-07 ,pp. : 1473-1479

Informa Healthcare

Access to resources Recommend Favorite

Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease

Current Medicinal Chemistry, Vol. 23, Iss. 19, 2016-07 ,pp. : 2055-2069

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy and safety of Cinacalcet on secondary hyperparathyroidism in Chinese chronic kidney disease patients receiving hemodialysis

Hemodialysis International, Vol. 20, Iss. 4, 2016-10 ,pp. : 589-600

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anticoagulation for Non‐Valvular Atrial Fibrillation in Older People

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 42, Iss. 3, 2012-09 ,pp. : 228-234

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and efficacy of pharmacological cardioversion of atrial fibrillation using intravenous vernakalant, a new antiarrhythmic drug with atrial selectivity

By Blomström-Lundqvist Carina Blomström Per

Expert Opinion on Drug Safety, Vol. 11, Iss. 4, 2012-07 ,pp. : 671-679

Informa Healthcare

Access to resources Recommend Favorite